Join Us at Chandigarh Pharma Summit
#ChandigarhPharmaSummit
About the Event
With India’s pharma sector at a pivotal juncture, the focus must now shift to sustainable leadership, impactful innovation, and strategic global collaborations. As regulatory frameworks tighten, competitive dynamics shift, and healthcare needs become more complex, Indian pharma must chart a strategic course toward global excellence. Therefore, Express Pharma intends to organise pharma summits at key pharma hubs across the country. The aim is to set the course for the next decade of growth, ensuring India Pharma Inc’s continued dominance in the international market.
'Pathways for global excellence' is the overarching theme for this year’s Pharma Summits. They will bring together industry leaders, policymakers, investors, and innovators to chart India Pharma Inc’s trajectory and transformation into a high-value, research-driven, and globally competitive powerhouse. They will highlight the industry’s need to evolve beyond cost-competitiveness to focus on quality, innovation, compliance, and supply chain resilience. Experts will also discuss and deliberate on R&D strategies, next-gen manufacturing, regulatory harmonisation, and sustainable practices to elevate India’s standing in global healthcare markets. Some of the key locations identified for this year’s summits are Ahmedabad, Chandigarh, Bengaluru, Vishakhaptnam and Indore. Read more
Access to a large market
With easy access to important markets like Delhi, Punjab, Haryana, and Himachal Pradesh, Chandigarh is strategically located in North India. As a result, businesses may see an increase in revenues and market penetration.
Skilled workforce
With numerous renowned educational institutions in the city, it has a highly skilled and competent workforce. This can save businesses on recruitment and training costs by assisting them in finding skilled and qualified personnel for their operations.
Favorable business environment
The Chandigarh government provide a range of subsidies and incentives to encourage investment in the pharmaceutical industry. This comprises allotments of land, tax exemptions, and capital investment subsidies. This can lower operating expenses for businesses and increase their profitability.
Availability of infrastructure
The region has a well-developed infrastructure in terms of transportation, communication, and utilities. This can assist businesses in streamlining their operations and reducing logistics costs.
Research and development opportunities
The extensive network of hospitals and research facilities in Chandigarh offers many chances for partnerships and cooperation. This can help companies develop innovative products and technologies, enhancing their competitiveness.
Upcoming bulk drug park in Una
The new bulk drug park is coming up in Haroli in Una district, nearly 126 km from Chandigarh. It will help in the production of quality raw materials and also bring down the cost of manufacturing of bulk drugs. And it is targeted to be ready by March 31, 2026.
Quality of life
Chandigarh is known for its high standard of living, with modern amenities, good healthcare facilities, and a clean and green environment. This can help companies attract and retain talented professionals, improving their competitiveness.
Panel DiscussionBuilding a high-value pharma destination: Making Chandigarh–Baddi investor-ready
Smart pharma manufacturing: Enabling digital, green, and scalable growth
Elevating quality culture across pharma hubs
Biotech and biosimilars: Can Chandigarh be a future biopharma hub?
Future pharma workforce: Bridging skill gaps in R&D, digital, and manufacturing
Strengthening academia-industry linkages: Unlocking NIPER’s innovation potential
Panel Discussion Pharma 2030 Creating a future-ready, responsible, and resilient sector
Dr Pirthipal Singh
Head-R&D, Tirupati Group
Dr Sukhjeet Singh
Chief Scientific Officer, Acme Formulation
Mr Shivaji Chakraborty
Head - Packaging Development, Fresenius Kabi Oncology
Mr Dhairy Sharma
Manager - Business Development (Healthcare Division), CILICANT
Dr Shankar Varaganti
Commercial Marketing Manager, Merck
Dr Vellaian Karuppiah
COO, Acme & Immacule Group of Companies
Mr Jawaid Imam
Sr VP, Aristo Pharmaceuticals
Dr Ashok P
Plant Head, Welzo Research & Development
Mr Ravi Bhardwaj
VP-Quality, Ind-Swift
Dr Saurabh Pandey
Cluster Head-Quality Control, Sun Pharma
Ms Suman Sharma
Head of Quality, Indchemie Health Specialities
Mr Gursharanjit Singh
Unit Head- Manufacturing Operations FTO-8, Dr Reddy's Laboratories
Mr Rajan Ramalingam
Senior Partner, InACE Pharma Consulting
Mr Soumaya Dutt
Sr GM & Site Head, Glenmark Pharmaceuticals
Dr Sujeet Shrivastava
Head (GM) – Analytical R&D, Synthimed Labs, R&D Centre, Mohali
Express Pharma, first published as Express Pharma Pulse in 1994, is today India’s leading business fortnightly for the pharmaceutical industry. With the patronage of its readers, Express Pharma has grown to become the No.1 Business News Magazine for the pharmaceutical industry. The editorial contents include: news, views, analysis and interviews, under four main segments: Market (The business of pharmaceuticals), Management (Insight for managing pharma), Research (Expertise for drug development) and Pharma Life (HR issues with a pharma focus). Besides this, we bring out periodic specials like the quarterly Pharma Technology Review, Packaging Special and LABNEXT.
